|
|
|
|
||
ASM: Lymphoseek Australian distributor contracted and supplying 1 to 2 hospitals, India awaiting governmental approval for LS expected over next few quarters(guess dist/markt'r), in EU Norgine still distributing awaiting governmental distributor approval India guess distributor/marketer...ummmmmm Jubilant? (Warning
these comments were extracted using a free transcribing service, so word
and phrasing extraction from the ASM audio is probably only around 90%
to 95% accurate, so should not be read as or quoted verbatim and there is nil punctuation) "...Question: thank you Mike Rosol so one of the other questions that we received is about when or have lymphoseek sales started in Australia and what is going on in Europe with a distributor
I'm going to discuss that so right now in Australia we have an agreement in place with a distributor there and we have shipped them material which they will buy in advance and then they will sell and are currently selling to approximately one or two hospitals in Australia and we hope to continue to grow that market as it is true that we were set up where there is very incentivized to really increase the market over there it's also important to note that in Europe covid has certainly limited our ability to a head over there and negotiate with potential Partners face-to-face but in the face of all that we have still set up with a distributor there so we are ready to start distributing the product we are waiting for several key licenses as anybody has done business in Europe you know that there's a lot of regulatory stuff to go through there a lot of hurdles break that is made it even more difficult because you have your up and you have the UK as well we are currently waiting for the final official distributor license that make us a license distributor in the meantime we'd like to thank norgine as they have been cooperative and they have been continuing to fill orders it's important to note that given what went on to Black and the price of the mismatch between the pricing and the demands we will be sort of resetting the bar on the lymphoseek pricing in Europe in order to regain some market share as we seen the US lymphoseek market share now represents greater than 50% thanks to cardinal which been very aggressive with their distribution and marketing over the last year and while we don't think we're going to get the 50% market share in Europe we do think that there is market share to be gained and the question is how big of a market with reduced pricing is going to be will definitely challenging due to the competition with several products but we are speaking with several potential Partners one of whom distributes one of the competing products and we think that with that we can get them to hopefully help us over long time so that's something that we are excited about that being said India is continuing to go through the regulatory it takes a long time there we expect to get approval sometime in the next several quarters and then we will start selling their that also won't be a large market but it will be a profitable market once we start telling thei..."r
|
return to message board, top of board |